全部最新消息

The WHA79 side event “Cancer Policy and Innovation: From Early Detection to Equitable Treatment” will be held in Geneva, Switzerland, on 18 May 2026.

Cancer remains one of the leading causes of death and a profound global health burden, contributing to approximately 10 million deaths in 2020. A significant proportion of cancers can be effectively managed or cured if detected early and treated promptly.

In Taiwan, cancer has consistently been the leading cause of death for the past 43 years, resulting in more than 50,000 deaths annually and placing a heavy burden on individuals, families, and society. Under the “Healthy Taiwan” initiative, Taiwan has launched a “three-pronged approach to combating cancer,” which encompasses improving early-stage cancer screening, focusing on genetic testing and precision medicine, and establishing a NT$10 billion new cancer drugs fund. These measures aim to enhance patients’ access to high-value care and optimize reimbursement mechanisms, thereby advancing timely, equitable, and affordable cancer prevention and treatment.

On the margins of the 79th World Health Assembly, Taiwan’s Ministry of Health and Welfare (MOHW) will convene international experts to exchange policy practices and innovative experiences, with the goal of fostering early detection, equitable treatment, and multilateral collaboration. The forum will explore critical themes, including: enhancing the coverage and quality of cancer screening via digital health innovations; optimizing the reimbursement and affordability of precision and innovative therapies; and building more comprehensive international partnerships to advance cancer health equity. Through this high-level dialogue, we aim to catalyze collective action to alleviate the global cancer burden and secure a healthier future for all.



【Information】
Title: Cancer Policy and Innovation: From Early Detection to Equitable Treatment
Time: 14:00-17:00 Monday, 18 May 2026 (UTC+2)
Event Registration: https://forms.gle/aFhYMUn5WxGhXGxt6

【Contact】
Email: chiehyu@mpat.org.tw (Ms. Yang)
 

    WHA79周邊會議「癌症政策與創新：從早期發現到公平治療（Cancer Policy and Innovation: From Early Detection to Equitable Treatment）」將於2026年5月18日在瑞士日內瓦舉行。

    癌症為全球主要死因和健康負擔之一， 2020年約造成1,000萬人死亡。多數癌症若能及早發現並及時治療，將有更高的治癒與存活機會。

    在臺灣，將有更高的治癒與存活機會，每年造成逾5萬例死亡，對個人、家庭及社會體系均帶來沉重負擔。於「健康臺灣」倡議中，臺灣推動癌症防治的「三支箭」，包括「提升早期癌症篩檢」、「聚焦基因檢測與精準醫療」及「建立百億癌症新藥基金」。協助患者取得必要服務、並取得衛生體系給付，以促進即時、公平和可負擔的癌症防治服務。

    第79屆世界衛生大會期間，臺灣衛生福利部將邀集國際專家共同交流政策實務與創新經驗，以促進早期發現、公平治療及跨國合作。論壇將聚焦多項關鍵議題，包含強化癌症篩檢的覆蓋率、品質和導入創新技術；改善精準與創新療法的給付和可負擔性；以及建立更全面的國際合作與交流，來縮小癌症防治的不平等，以有助於降低癌症的全球負擔。   

透過此次高層次對話，我們期盼促成全球集體行動，減輕癌症所帶來的健康負擔，並為全民打造更健康的未來。



【活動資訊】
時間：2026年5月18日（一）14:00-17:00（歐洲中部時間）
地點：Hotel President Wilson（W廳），瑞士日內瓦
報名連結：https://forms.gle/Q9nrPRuyTa82vTKo8
【聯絡資訊】
Email: chiehyu@mpat.org.tw (楊小姐)
 

The WHA79 side event “Global Hepatitis C Elimination: Experience and the Road Ahead” will be held in Geneva, Switzerland, on 19 May  2026.

In proactive alignment with these global priorities, Taiwan has spearheaded the “Taiwan Hepatitis C Policy Guideline 2018–2025.” This framework is anchored by three core strategies: "Precision Public Health,” “Localized Care Delivery,” and a “Continuum of Care.” This approach is further operationalized through a synergistic policy triad: “Therapy Spearheads Prevention,” “Screening Supports Therapy,” and “Prevention Secures Outcomes.”

Through these rigorous interventions, Taiwan successfully reached its elimination targets in 2025, attaining this milestone five years ahead of the WHO’s 2030 schedule. Taiwan’s national performance has surpassed the WHO “Path to Elimination” Gold Tier standards, maintaining diagnosis and treatment rates exceeding 90% while achieving 100% coverage in injection safety and blood screening efficacy.

On the margins of the 79th World Health Assembly, Taiwan’s Ministry of Health and Welfare (MOHW) will convene a high-level strategic forum to catalyze multilateral knowledge exchange among international experts and stakeholders. This event serves as a premier platform to synthesize transformative health models and collectively navigate the complexities of the post-elimination landscape.

The forum will feature a comprehensive exploration of scalable success stories and the pivotal role of civil society, while addressing the strategic imperatives of maintaining sustainability in the post-elimination era. By synergizing national and international action plans toward 2030, we aim to make a decisive contribution to the global mission to secure a hepatitis-free future.



【Information】
Title: Global Hepatitis C Elimination: Experience and the Road Ahead
Time: 09:00-12:00 Tuesday, 19 May 2026 (UTC+2)
Event Registration: https://forms.gle/aFhYMUn5WxGhXGxt6

【Contact】
Email: chiehyu@mpat.org.tw (Ms. Yang)
 

WHA79周邊會議「全球C型肝炎消除：經驗與未來之路（Global Hepatitis C Elimination: Experience and the Road Ahead）」將於2026年5月19日在瑞士日內瓦舉行。

APACPH 2026 年第 1 次執行委員會會議

本會邱弘毅理事長與邱亞文秘書長率APACPH代表團拜會馬來亞大學，推動亞太公共衛生學術合作

APACPH 參與 2026 年 PMAC 全球公共衛生學院院長高峰會

恭賀!! 本會邱弘毅理事長 接任亞太公共衛生學術聯盟理事長

由本會與亞太公共衛生學術聯盟（Asia-Pacific Academic Consortium of Public Health, APACPH）下設置的健康促進協作中心 (Collaborating Centres for Health Promotion, CCHP)、衛福部國民健康署共同主辦；國家衛生研究院群體健康科學研究所衛生政策研究中心及臺灣公衛學生聯合會協辦，於8月26日至27日假國立臺灣大學公共衛生學院舉辦一年一度的「2025亞太健康促進與非傳染病防治教育訓練工作坊」。

「亞太健康促進與非傳染病防治教育訓練」工作坊公開演講

WHA周邊論壇「運用智慧科技提升醫療可近性（Empowering through Inclusive Healthcare: Leveraging Smart Technologies for Accessibility）」

新作分享!!
這篇文章是由本會羅偉成副秘書長與臺灣疾病負擔中心團隊利用癌症登記資料與死因登錄資料，回顧並推估臺灣過去20年來癌症負擔的變化。